Esbriet Interactions
There are 153 drugs known to interact with Esbriet (pirfenidone), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 20 are major, 130 are moderate, and 3 are minor.
- View all 153 medications that may interact with Esbriet
- View Esbriet alcohol/food interactions (1)
- View Esbriet disease interactions (3)
Most frequently checked interactions
View interaction reports for Esbriet (pirfenidone) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- azithromycin
- benzonatate
- Eliquis (apixaban)
- finasteride
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluticasone nasal
- furosemide
- gabapentin
- ibuprofen
- Kalydeco (ivacaftor)
- Lasix (furosemide)
- levothyroxine
- losartan
- metformin
- Metoprolol Succinate ER (metoprolol)
- Ofev (nintedanib)
- omeprazole
- pantoprazole
- potassium chloride
- prednisone
- Repatha (evolocumab)
- tamsulosin
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Esbriet alcohol/food interactions
There is 1 alcohol/food interaction with Esbriet (pirfenidone).
Esbriet disease interactions
There are 3 disease interactions with Esbriet (pirfenidone) which include:
Report options
QR code containing a link to this page
More about Esbriet (pirfenidone)
- Esbriet consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (11)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
